Internal Medicine, Gastroenterology · Houston, TX
NPI
1578767166
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
6550 Fannin St, Suite 1201
Houston, TX, 77030
Phone (713) 441-3372
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
79,224 services
Medicare patients, 2024
199
Average age 71
Drug cost, 2024
$7.1M
1,209 prescriptions
Company payments, 2025
$183K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bincy P Abraham was code J3380 (injection, vedolizumab, intravenous, 1 mg), 46,200 times for 22 patients. In total Bincy P Abraham billed 79,224 services in 41 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 46,200 | 22 | $15.08 | $697K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 6,291 | 13 | $24.94 | $157K |
| 96413 Chemotherapy Administration | Office | 299 | 46 | $89.32 | $27K |
| 99232 Hospital E&M - Subsequent | Facility | 81 | 51 | $61.59 | $4,989 |
| 99214 Office E&M - Established | Office | 60 | 54 | $93.78 | $5,627 |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 54 | 50 | $38.38 | $2,073 |
| 93976 Duplex Scan - Extremity Arteries | Office | 54 | 50 | $102.22 | $5,520 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 53 | 49 | $88.24 | $4,677 |
| 45380 Lower GI Endoscopy - Other | Facility | 38 | 37 | $121.06 | $4,600 |
| 99222 Hospital E&M - Initial | Facility | 31 | 31 | $94.83 | $2,940 |
| 99233 Hospital E&M - Subsequent | Facility | 20 | 16 | $86.91 | $1,738 |
| 43239 Upper GI Endoscopy | Facility | 13 | 13 | $90.66 | $1,179 |
| 45385 Colonoscopy - Lesion Removal | Facility | 11 | 11 | $211.06 | $2,322 |
By year: 2022 $1.4M for 62,184 services; 2023 $1.0M for 68,110 services; 2024 $1.2M for 79,224 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bincy P Abraham prescribed most often to Medicare patients was Stelara (Ustekinumab), with 121 prescriptions and refills. In total Bincy P Abraham wrote 1,209 Medicare prescriptions that cost $7.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 121 | 158 | 16 | $3.3M |
| Humira(Cf) Pen Adalimumab | 73 | 77 | Under 11 | $698K |
| Amitriptyline Hcl Generic | 62 | 72 | 11 | $669 |
| Mesalamine Generic | 61 | 118 | 19 | $35K |
| Dicyclomine Hcl Generic | 55 | 75 | 19 | $1,722 |
| Promethazine Hcl Generic | 46 | 46 | Under 11 | $1,399 |
| Omeprazole Generic | 46 | 104 | 19 | $676 |
| Ondansetron Odt Ondansetron | 43 | 43 | 13 | $1,651 |
| Rinvoq Upadacitinib | 35 | 43 | Under 11 | $314K |
| Diphenhydramine Hcl Generic | 34 | 35 | Under 11 | $1,075 |
| Azathioprine Generic | 32 | 58 | Under 11 | $881 |
| Skyrizi On-Body Risankizumab-Rzaa | 31 | 54 | Under 11 | $642K |
| Simponi Golimumab | 28 | 33 | Under 11 | $307K |
| Pantoprazole Sodium Generic | 28 | 64 | 13 | $577 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 28 | 28 | 28 | $4,721 |
Brand drugs: 505 claims; generic drugs: 690 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bincy P Abraham $183K ($183K in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $38K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 75 | $38K |
| Janssen Biotech, Inc. JNJ | 52 | $35K |
| Celltrion USA Inc. 068270.KS | 25 | $25K |
| Lilly USA, LLC LLY | 16 | $22K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 17 | $18K |
| Pfizer Inc. PFE | 21 | $18K |
| F. Hoffmann-La Roche AG ROG.SW | 4 | $13K |
| Genzyme Corporation SNY | 8 | $5,447 |
| Janssen Scientific Affairs, LLC JNJ | 10 | $4,984 |
| Ironwood Pharmaceuticals, Inc IRWD | 1 | $1,300 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.